Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01723163 · ClinicalTrials.gov registry record · NA

Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
310
Enrollment target

NCT01723163: Completed NA study, sponsored by VA Office of Research and Development.

NCT01723163 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 310 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01723163, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
310 participants
Enrollment target

Study Summary

The primary goal of the current study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that investigators are calling Abstinence Reinforcement Therapy (ART). Proposed is a comparative effectiveness trial with a two-group design in which 310 Veteran smokers will be randomized to either: ABSTINENCE REINFORCEMENT THERAPY (ART) a proactive tele-health intervention that combines guideline based cognitive-behavioral telephone counseling (TC), a tele-medicine clinic for access to nicotine replacement (NRT), and intensive behavioral therapy through mobile contingency management. TELE-HEALTH FOR SMOKING CESSATION a proactive tele-health intervention that will provide controls for therapist, medication, time and attention effects. The tele-health intervention provides the same guideline based cognitive-behavioral smoking cessation telephone counseling (TC), and tele-medicine clinic for access to NRT as in the ART intervention.

Primary Outcome

Non-abstinence is defined as smoking for 7 consecutive days or at least once a week for 2 consecutive weeks. Non-abstinence was evaluated for the 90 days previous to the 6 month follow-up.

Interventions

  • BEHAVIORAL Abstinence Reinforcement Therapy (ART)
  • BEHAVIORAL Telephone Counseling and NRT

Trial Details

FieldValue
Enrollment Target 310 participants
Start Date 2013-11-21
Est. Completion 2017-09
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT01723163 record still lists

NCT01723163 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 2 interventions - of which Abstinence Reinforcement Therapy (ART) is the first listed.

NCT01723163 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01723163 about?

NCT01723163 is a clinical study titled "Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers". The primary goal of the current study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that investigators are calling Abstinence Reinforcement Therapy (ART). Proposed is a comparative effectiveness trial with a two-group design in which 310 Vete...

What is the current status of trial NCT01723163?

This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2013-11-21. Estimated completion is 2017-09.

What interventions are being tested in trial NCT01723163?

The interventions under investigation include: Abstinence Reinforcement Therapy (ART) (BEHAVIORAL), Telephone Counseling and NRT (BEHAVIORAL).

Who is sponsoring clinical trial NCT01723163?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01723163's enrollment target sits among peer trials

310 323rd of 2000 higher than 1,678 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03039439 · 310 participants

    Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

  • NCT04178018 · 310 participants · NA

    Transvaginal Ultrasound and Photoacoustic Imaging of Ovary

  • NCT04878094 · 310 participants · Phase 3

    A Study of Intra-operative Imaging in Women With Ovarian Cancer

  • NCT05459233 · 310 participants · NA

    Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01723163, the US trial registry maintained by the National Library of Medicine. NCT01723163 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.